Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Localized Pancreatic Ductal Adenocarcinoma”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Testing effectiveness (Phase 2)Looking for participantsNCT05132504
What this trial is testing

Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Baylor College of Medicine 30
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Temporarily pausedNCT00637364
What this trial is testing

High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain

Who this might be right for
PainPancreatic AdenocarcinomaDuctal Adenocarcinoma
CMED HIFU Development Corporation 5
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)UnknownNCT05048524
What this trial is testing

Peri-operative SLOG for Localized Pancreatic Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreas Cancer
National Health Research Institutes, Taiwan 64
Testing effectiveness (Phase 2)Looking for participantsNCT05518903
What this trial is testing

Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma

Who this might be right for
Localized Pancreatic AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaStage 0 Pancreatic Cancer AJCC v8+2 more
Mayo Clinic 130
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Testing effectiveness (Phase 2)Looking for participantsNCT05984810
What this trial is testing

NIR-Fluorescence Guided Surgical Resection of Neoadjuvant Treated Localized Pancreatic Cancer Using SGM-101

Who this might be right for
Pancreas Adenocarcinoma
Leiden University Medical Center 20
Early research (Phase 1)WithdrawnNCT04852367
What this trial is testing

PanDox: Targeted Doxorubicin in Pancreatic Tumours

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic Cancer Stage IVPancreatic Cancer Non-resectable+1 more
University of Oxford
Testing effectiveness (Phase 2)Looking for participantsNCT06048484
What this trial is testing

Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Gulam Manji 60
Testing effectiveness (Phase 2)Study completedNCT03727880
What this trial is testing

Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma

Who this might be right for
Resectable Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Ductal Adenocarcinoma
Lei Zheng 28
Early research (Phase 1)Not Yet RecruitingNCT07645651
What this trial is testing

Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic Ductal AdenocarcinomaLocally Advanced Pancreatic Ductal Adenocarcinoma
University of Washington 15
Post-approval studies (Phase 4)Active Not RecruitingNCT05634720
What this trial is testing

Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Duke University 20
Not applicableLooking for participantsNCT07124611
What this trial is testing

A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer

Who this might be right for
Localized Pancreatic Ductal AdenocarcinomaStage 0 Pancreatic Cancer AJCC v8Stage I Pancreatic Cancer AJCC v8+1 more
Ohio State University Comprehensive Cancer Center 60
Not applicableLooking for participantsNCT05752812
What this trial is testing

The HELPP Score: A Pretreatment Score to Predict Survival in Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Medical University of Vienna 1,500
Not applicableStudy completedNCT06699667
What this trial is testing

CT Findings in Surgically Treated Focal Pancreatic Disease- A Retrospective Study

Who this might be right for
Autoimmune Pancreatitis
Rigshospitalet, Denmark 41
Testing effectiveness (Phase 2)Ended earlyNCT05289830
What this trial is testing

Escitalopram to Placebo in Patients With Localized Pancreatic Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaPeriampullary Cancer
Case Comprehensive Cancer Center 4